XML 22 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development, net of grant reimbursement $ 24,969 $ 16,948 $ 47,089 $ 31,854
General and administrative 3,808 2,969 8,200 5,884
Total operating expenses 28,777 19,917 55,289 37,738
Operating loss (28,777) (19,917) (55,289) (37,738)
Interest income 2,198 314 4,249 345
Other income, net 203 275 393 538
Net loss $ (26,376) $ (19,328) $ (50,647) $ (36,855)
Net income (loss) per share        
Net loss per share, Basic $ (0.63) $ (0.48) $ (1.21) $ (0.92)
Net loss per share, Diluted $ (0.63) $ (0.48) $ (1.21) $ (0.92)
Weighted-average shares used in computing net income (loss) per share        
Shares used in computing net loss per share, basic 41,793 40,015 41,766 39,989
Shares used in computing net loss per share, diluted 41,793 40,015 41,766 39,989